Abstract

Thermospray high-performance liquid chromatography—mass spectrometry was used to confirm the identity of five bulk anticancer drugs, and in some cases, to identify drug impurities. Analysis resulted in both molecular weight and structural (fragment ions) information obtained from the full scan spectra of as little as 50 ng of each drug. The technique was also used to evaluate the chromatographic specificity of corresponding ultraviolet or refractive index high-performance liquid chromatographic detection in the presence of drug degradation products.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.